Mark Lappe 13D and 13G filings for Inhibrx Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:16 pm Purchase |
2023-12-31 | 13G | Inhibrx Biosciences, Inc. INBX |
Mark Lappe | 3,184,508 6.700% |
34,794 (+1.10%) |
Filing |
| 2021-02-12 4:19 pm Purchase |
2020-12-31 | 13G | Inhibrx Biosciences, Inc. INBX |
Mark Lappe | 3,149,714 8.400% |
3,149,714 (New Position) |
Filing |